Press Release
Article
Camber Pharmaceuticals is proud to expand its product line with Quetiapine Tablets, USP, offering patients a more affordable, high-quality treatment option.
Approximately 3.2 million Americans are affected by schizophrenia, while 5.7 million struggle with bipolar disorders. Camber Pharmaceuticals is proud to expand its product line with Quetiapine Tablets, USP, offering patients a high-quality treatment option. This addition supports our ongoing commitment to reducing drug shortages and improving access to essential medications.
Quetiapine Tablets, USP are an atypical antipsychotic indicated for the treatment of:
Quetiapine Tablets, USP is available in:
To learn more about Quetiapine Tablets, please visit www.camberpharma.com/quetiapine